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Background: Patients (pts) with hypertrophic cardiomyopathy (HCM) may present with a variety of symptoms, including sudden cardiac death. 
Sudden cardiac death due to ventricular fibrillation correlates with the extent of intramural fibrosis (IF). IF can be detected using cardiac magnetic 
resonance (CMR) by showing “late enhancement” (LE) in such areas. However, there are a number of CMR contraindications supporting the need 
for alternative imaging modalities. Cardiac CT was shown to demonstrate subendocardial LE following myocardial infarction. We now investigated 
Cardiac CT in HCM patients with IF.
methods: In an ongoing prospective study approved by the local ethics committee and the German Federal Office for Radiation Protection 
we recruit consecutive pts with echocardiographically suspected HCM (septum >15mm). For assessment of ventricular configuration, volumetry 
and IF all patients undergo cardiac CT followed by CMR for validation. Cardiac CT scans (64-slices; tube voltage 80 kV) are run 7 minutes after 
dye injection. Analysis of IF is based on multi-planar reconstructions (detection, intensity, volumetry) and the established 17-segment polar map 
(distribution). Planimetry is performed by both a skilled cardiologist and radiologist.
results: 27 pts were recruited (men n=16, women n=11; 65.0 ± 14.3 years of age; echo: septum 18.4 ± 2.2 mm, E/A 0.87 ± 0.29). Cardiac CT 
detected IF in 51.7 % (15/29 pts) whereas CMR demonstrated IF in 69.0 % (20/29 pts). IF distribution was congruent: segment 2 in 5 pts, segment 
3 in 2 pts, segment 4 in 2 pts, segment 5 in 3 pts, segment 6 in 1 pts, segment 8 in 2 pts, segment 9 in 1 pts, and segment 10 in 1 pts. Of note, in 
CMR artefacts were visible in 34.5 % (10/29 pts). In Cardiac CT, LE representing IF and non-enhanced myocardium revealed an average HU value 
of 130.79 ± 20.68 vs. 95.65 ± 15.26 (p 0.000024); IF volume was 4.9 ± 3.85 mm3. The intra-/interobserver variability was r=0.88 (p=0.37) and 
r=0.88 (p=0.41), respectively. The effective dose using our protocol was for men 3.43 ± 0.57 mSv and for women 4.98 ± 1.06 mSv.
conclusion: Cardiac CT can reliably detect, localize and quantify IF in HCM patients.
